Global Diabetes Reusable Insulin Pen Market Forecast 2017 - 2022

1
Global Diabetes Reusable Insulin Pen Market
Forecast 2017 - 2022
2
Summary
Diabetes Reusable Insulin Pen Market is likely to
reach more than US 3 Billion across the ten
major markets (10MM) of the United States,
France, Germany, Italy, Spain, United Kingdom,
Japan, China, India and Brazil by the year end of
2022. Market growth can be attributed to factors
such as growing diabetes patient population, high
adoption rate, userfriendly design, rising
popularity among consumers, help avoid
over/underdosing of insulin, rising market
demand for human insulin analogs, government
support and technological advancements in the
field of reusable insulin pen devices.
3
(No Transcript)
4
China is expected to lead the reusable insulin
pen market with a total market share of over 50
by 2022. Germany has shown its potential to
become leading 2 market with more than market
share in 2016 and is expected to maintain its 2
position during the forecast period. United
States is expected to become the third largest
reusable insulin pen market by 2022. The research
report titled Global Diabetes Reusable Insulin
Pen Market Report Country Outlook, Analysis,
Size, Share and Forecast 2017 2022 examines
the market, demand, competitive landscape and
trends of the ten major markets of the reusable
insulin pen market. The report provides an
indepth analysis of overall diabetes population
and insulin users. It provides essential insights
into reusable insulin pen market and users for
the top 10 countries, comprising the US, the UK,
France, Italy, Spain, Germany, Japan, China,
India and Brazil until 2022.
5

• The report concludes with the profiles of major
  players in the insulin pen market such as Novo
  Nordisk, Eli Lilly, Sanofi, Owen Mumford,
  Ypsomed, Biocon Ltd. The major market players are
  evaluated on various parameters such as company
  overview, product outlook and latest development
  and trends of the insulin pen market.
• All the Ten Major Markets(10MM) Covered in the
  Report Have Studied from 4 Viewpoints
• Overall Diabetes Population (2011 2022)
• Insulin Users (2011 2022)
• Reusable (Cartridge) Insulin Pen Users (2011
  2022)
• Reusable (Cartridge) Insulin Pen Market (2011
  2022)

6

• Ten Major Markets(10MM) Covered in the Report are
  as follows
• United States
• United Kingdom
• France
• Italy
• Spain
• Germany
• Japan
• China
• India
• Brazil

7

• Key Companies Covered in the Report are as
  follows
• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford
• Ypsomed
• Biocon Ltd.

8
Related Report

• 2016 Global Nanotechnology in Medical Devices
  Market Status, 2011-2022 Market Historical and
  Forecasts, Professional Market Research Report
• 2016 Global Medical Devices Market Status,
  2011-2022 Market Historical and Forecasts,
  Professional Market Research Report
• Qatari German Medical Devices (QGMD) - Financial
  and Strategic SWOT Analysis Review
• Chinese Special Examination and Approval
  Procedures for Innovative Medical Devices speed
  up overseas innovative medical devices entry into
  Chinese market
• Contract Research Organizations (CROs) Services
  Market by Type (Preclinical, Clinical Research,
  Laboratory), Therapeutic Area (Oncology, CNS,
  Cardiovascular), End User (Pharmaceutical,
  Biopharmaceutical Medical Device Companies) -
  Global Forecast to 2021

9
Full Report
Global Diabetes Reusable Insulin Pen Market
Forecast 2017 - 2022
Contact us at Bharat Book Bureau Tel 91 22
27810772 / 27810773 Email poonam_at_bharatbook.co Ou
r Blog https//www.bharatbook.com/blog/ Twitter
https//twitter.com/researchbook Facebook
https//www.facebook.com/BharatBook3B LinkedIn
http//www.linkedin.com/company/bharat-book-bureau